BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced…
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced…
MagnetOs U.S. Q1 sales accelerate, rising 117% over Q1 2020 European distribution network expansion ahead of schedul…
BlueRock Therapeutics LP, a leading engineered cell therapy company and a wholly-owned and independently operated subsid…
Generics are an off-patented drug that is pharmaceutical equivalents to branded medicines in term of administrative dosa…
. Mick Schumacher will make his debut in an official Formula One race weekend practice session when he will take the whe…
The Natural Products Association (NPA) recognized BASF for having the largest selection of ingredients for cosmetic man…
Gerresheimer has a total of 13 sites across Asia for its range of glass and plastic products. The company will be attend…
Financial highlights CHF 17.0 million cash at year-end CHF 16.9 million equity raise in June 2017 Standby equity facil…
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics thro…
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics thro…